subject: DRUGBANK:DB16481

subject_name: Dociparstat sodium

object_name: Recurrent Malignant Solid Neoplasm


subject: DRUGBANK:DB16481

object_name: Wilms tumor 1

tested_intervention: yes


subject: DRUGBANK:DB16481

object_name: nephroblastoma


subject: DRUGBANK:DB16481

object_name: Wilms tumor


subject: DRUGBANK:DB16481

object_name: Childhood Neuroblastoma


subject: DRUGBANK:DB16481

object_name: neuroblastoma


subject: DRUGBANK:DB16481

object_name: malignant soft tissue neoplasm


subject: DRUGBANK:DB16481

object_name: sarcoma


subject: CHEBI:195558

subject_name: Entrectinib

object_name: invasive lobular breast carcinoma

tested_intervention: unsure


subject: CHEBI:195558

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:195558

object_name: Her2-receptor negative breast cancer


subject: CHEBI:5523

subject_name: Goserelin


subject: CHEBI:6413

subject_name: Letrozole


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: vitamin D-dependent rickets, type 2


subject: UNII:NQX9KB6PCL

object_name: hypophosphatemic rickets


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: CHEBI:142094

subject_name: (S)-S-adenosyl-L-methionine zwitterion

object_name: hepatitis A


subject: CHEBI:142094

object_name: hepatitis


subject: CHEBI:15414

subject_name: Adomet


subject: CHEBI:15414


subject: CHEBI:67040

subject_name: Ademetionine


subject: CHEBI:67040


subject: UMLS:C0031788

subject_name: Phycocyanin

object_name: liver cirrhosis


subject: UMLS:C0031788

object_name: Liver Fibrosis


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin

object_name: adhesions of uterus


subject: UMLS:C0025326

subject_name: Menotropins


subject: UMLS:C5203412

subject_name: Midazolam Liquid Injection

object_name: Gastro-esophageal reflux disease with ulceration


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:597326

subject_name: pyridoxal 5'-phosphate(2-)

object_name: myocardial ischemia


subject: CHEBI:597326

object_name: coronary atherosclerosis


subject: CHEBI:597326

object_name: Reperfusion Injury


subject: CHEBI:17310

subject_name: Pyridoxal


subject: CHEBI:17310


subject: CHEBI:17310


subject: CHEBI:75431

subject_name: ghrelin

object_name: Ischemic stroke


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: UMLS:C0911014


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: refractory malignant neoplasm


subject: CHEBI:91397

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:91397

object_name: Recurrent Carcinoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: DRUGBANK:DB16181

subject_name: ISIS 2503

object_name: colorectal cancer


subject: DRUGBANK:DB16181

object_name: colorectal carcinoma


subject: DRUGBANK:DB16181

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Male infertility due to hypospermatogenesis


subject: CHEMBL.COMPOUND:CHEMBL2107856

subject_name: IMETELSTAT

object_name: non-small cell lung carcinoma


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: classic Kaposi sarcoma


subject: UNII:DPT0O3T46P

object_name: Refractory Kaposi Sarcoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994

object_name: Kaposi Sarcoma


subject: CHEBI:85994


subject: CHEBI:7772

subject_name: omeprazole

object_name: food allergy


subject: CHEBI:77260

subject_name: Omeprazole


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Metastatic non-small cell lung cancer


subject: UNII:8M7YSN2KII

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:8M7YSN2KII

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Tension-type headache


subject: CHEBI:49603

subject_name: Lapatinib

object_name: salivary gland adenoid cystic carcinoma


subject: CHEBI:49603

object_name: Salivary Gland Low Grade Carcinoma


subject: CHEBI:49603

object_name: Adenocarcinoma of salivary gland


subject: CHEBI:49603

object_name: Salivary Gland High Grade Carcinoma


subject: CHEBI:49603

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:49603

object_name: salivary gland acinic cell carcinoma


subject: CHEBI:49603

object_name: malignant mixed neoplasm


subject: CHEBI:49603

object_name: Salivary Gland Low Grade Mucoepidermoid Carcinoma


subject: CHEBI:49603

object_name: Salivary Gland High Grade Mucoepidermoid Carcinoma


subject: UMLS:C5565911

object_name: pemphigus vulgaris


subject: UMLS:C5565911

object_name: pemphigus foliaceus


subject: CHEBI:85994

object_name: Hepatic impairment


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Secondary Sjögren's syndrome


subject: UNII:7D0YB67S97

object_name: Primary Sjögren's syndrome


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C1704263

subject_name: green tea extract

object_name: Oral Mucositis


subject: UMLS:C1704263

object_name: stomatitis


subject: UMLS:C1704263

object_name: oral mucositis


subject: UMLS:C1704263

object_name: head and neck squamous cell carcinoma


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307


subject: DRUGBANK:DB14307


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: UMLS:C0378942

object_name: myocarditis


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: PUBCHEM.COMPOUND:3477613

subject_name: sPLA2 inhibitor

object_name: Sepsis


subject: PUBCHEM.COMPOUND:3477613

object_name: Sepsis, CTCAE


subject: CHEBI:3752

subject_name: Clomifene

object_name: Subfertility


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin


subject: UNII:5Y9QQM372Q

subject_name: MENOTROPINS


subject: UMLS:C0025326

subject_name: Menotropins


subject: UMLS:C4329337

subject_name: TAB 001

object_name: adult lymphoma


subject: UMLS:C4329337

object_name: pediatric lymphoma


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: West Nile viral infection


subject: UNII:XRO4566Q4R

object_name: West Nile Fever Myelitis


subject: UNII:XRO4566Q4R

object_name: West-Nile encephalitis


subject: UNII:XRO4566Q4R

object_name: West Nile Fever with other complications


subject: CHEBI:4471

subject_name: dextromethorphan hydrobromide

object_name: Adult Solid Neoplasm


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:27999

subject_name: Tolbutamide


subject: CHEBI:151315

subject_name: Heparin

object_name: heart failure


subject: CHEBI:151315

object_name: Heart Failure, CTCAE


subject: KEGG.COMPOUND:C00374

object_name: respiratory failure


subject: KEGG.COMPOUND:C00374

object_name: Respiratory Failure, CTCAE


subject: KEGG.COMPOUND:C00374


subject: KEGG.COMPOUND:C00374


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Hemorrhage


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: MESH:D006495


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: CHEBI:74705

subject_name: Met-Leu

object_name: prostate carcinoma


subject: CHEBI:74705

object_name: prostate cancer


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C5854486

subject_name: c-Met Inhibitor DO-2

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854486

object_name: Refractory Neoplasm


subject: UMLS:C5854486


subject: UMLS:C5854486

object_name: non-small cell lung carcinoma


subject: UMLS:C5854486

object_name: Non-small cell carcinoma


subject: UMLS:C5854486

object_name: lung cancer


subject: UMLS:C5854486

object_name: lung neoplasm


subject: UMLS:C5854486

object_name: lung carcinoma


subject: CHEBI:167309

subject_name: Methadone

object_name: spinal cord injury


subject: CHEBI:167309

object_name: Amputation, Traumatic


subject: UMLS:C1170198

subject_name: Duac

object_name: acne


subject: UNII:308PA1L567

subject_name: Endoxifen Hydrochloride

object_name: malignant neoplasm of breast stage I


subject: UNII:308PA1L567

object_name: Stage IA Breast Cancer AJCC v7


subject: UNII:308PA1L567

object_name: Stage IB Breast Cancer AJCC v7


subject: UNII:308PA1L567

object_name: breast carcinoma in situ


subject: UNII:308PA1L567

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:308PA1L567

object_name: Stage IIA Breast Carcinoma


subject: UNII:308PA1L567

object_name: Stage IIB Breast Carcinoma


subject: UNII:308PA1L567

object_name: ductal breast carcinoma in situ


subject: UNII:308PA1L567

object_name: lobular breast carcinoma in situ


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UMLS:C2987366


subject: UNII:BQ94Z7E5OR

subject_name: Tocladesine

object_name: colorectal cancer


subject: UNII:BQ94Z7E5OR

object_name: colorectal carcinoma


subject: UNII:BQ94Z7E5OR

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:3K5H4TX2KP

subject_name: COBOLIMAB

object_name: liver neoplasm


subject: UNII:3K5H4TX2KP

object_name: diffuse intrinsic pontine glioma


subject: UNII:3K5H4TX2KP

object_name: liver carcinoma


subject: UNII:3K5H4TX2KP

object_name: glioblastoma


subject: UNII:3K5H4TX2KP

object_name: fibrolamellar hepatocellular carcinoma


subject: UNII:3K5H4TX2KP

object_name: Adult Rhabdomyosarcoma


subject: UNII:3K5H4TX2KP

object_name: rhabdomyosarcoma


subject: UNII:3K5H4TX2KP

object_name: Childhood Rhabdomyosarcoma


subject: UNII:3K5H4TX2KP

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:3K5H4TX2KP

object_name: Hodgkin Disease


subject: UNII:3K5H4TX2KP

object_name: Adult Hodgkin Lymphoma


subject: UNII:3K5H4TX2KP

object_name: Childhood Hodgkin Lymphoma


subject: UNII:3K5H4TX2KP

object_name: hepatoblastoma


subject: UNII:3K5H4TX2KP

object_name: pediatric osteosarcoma


subject: UNII:3K5H4TX2KP

object_name: Osteosarcoma


subject: UNII:3K5H4TX2KP

object_name: glioma susceptibility 1


subject: UNII:3K5H4TX2KP

object_name: ependymoma


subject: UNII:3K5H4TX2KP

object_name: childhood ependymoma


subject: UNII:3K5H4TX2KP

object_name: Newly Diagnosed Childhood Ependymoma


subject: UNII:3K5H4TX2KP

object_name: Adult Ependymoma


subject: UNII:3K5H4TX2KP

object_name: melanoma


subject: UMLS:C4287698

subject_name: Cobolimab

object_name: liver neoplasm


subject: UMLS:C4287698

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C4287698

object_name: liver carcinoma


subject: UMLS:C4287698

object_name: glioblastoma


subject: UMLS:C4287698

object_name: fibrolamellar hepatocellular carcinoma


subject: UMLS:C4287698

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C4287698

object_name: rhabdomyosarcoma


subject: UMLS:C4287698

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C4287698

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C4287698

object_name: Hodgkin Disease


subject: UMLS:C4287698

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C4287698

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4287698

object_name: hepatoblastoma


subject: UMLS:C4287698

object_name: pediatric osteosarcoma


subject: UMLS:C4287698

object_name: Osteosarcoma


subject: UMLS:C4287698

object_name: glioma susceptibility 1


subject: UMLS:C4287698

object_name: ependymoma


subject: UMLS:C4287698

object_name: childhood ependymoma


subject: UMLS:C4287698

object_name: Newly Diagnosed Childhood Ependymoma


subject: UMLS:C4287698

object_name: Adult Ependymoma


subject: UMLS:C4287698

object_name: melanoma


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: liver neoplasm


subject: UNII:P0GVQ9A4S5

object_name: diffuse intrinsic pontine glioma


subject: UNII:P0GVQ9A4S5

object_name: liver carcinoma


subject: UNII:P0GVQ9A4S5

object_name: glioblastoma


subject: UNII:P0GVQ9A4S5

object_name: fibrolamellar hepatocellular carcinoma


subject: UNII:P0GVQ9A4S5

object_name: Adult Rhabdomyosarcoma


subject: UNII:P0GVQ9A4S5

object_name: rhabdomyosarcoma


subject: UNII:P0GVQ9A4S5

object_name: Childhood Rhabdomyosarcoma


subject: UNII:P0GVQ9A4S5

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:P0GVQ9A4S5

object_name: Hodgkin Disease


subject: UNII:P0GVQ9A4S5

object_name: Adult Hodgkin Lymphoma


subject: UNII:P0GVQ9A4S5

object_name: Childhood Hodgkin Lymphoma


subject: UNII:P0GVQ9A4S5

object_name: hepatoblastoma


subject: UNII:P0GVQ9A4S5

object_name: pediatric osteosarcoma


subject: UNII:P0GVQ9A4S5

object_name: Osteosarcoma


subject: UNII:P0GVQ9A4S5

object_name: glioma susceptibility 1


subject: UNII:P0GVQ9A4S5

object_name: ependymoma


subject: UNII:P0GVQ9A4S5

object_name: childhood ependymoma


subject: UNII:P0GVQ9A4S5

object_name: Newly Diagnosed Childhood Ependymoma


subject: UNII:P0GVQ9A4S5

object_name: Adult Ependymoma


subject: UNII:P0GVQ9A4S5

object_name: melanoma


subject: UMLS:C4287697

object_name: liver neoplasm


subject: UMLS:C4287697

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C4287697

object_name: liver carcinoma


subject: UMLS:C4287697

object_name: glioblastoma


subject: UMLS:C4287697

object_name: fibrolamellar hepatocellular carcinoma


subject: UMLS:C4287697

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C4287697

object_name: rhabdomyosarcoma


subject: UMLS:C4287697

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C4287697

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C4287697

object_name: Hodgkin Disease


subject: UMLS:C4287697

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C4287697

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C4287697

object_name: hepatoblastoma


subject: UMLS:C4287697

object_name: pediatric osteosarcoma


subject: UMLS:C4287697

object_name: Osteosarcoma


subject: UMLS:C4287697

object_name: glioma susceptibility 1


subject: UMLS:C4287697

object_name: ependymoma


subject: UMLS:C4287697

object_name: childhood ependymoma


subject: UMLS:C4287697

object_name: Newly Diagnosed Childhood Ependymoma


subject: UMLS:C4287697

object_name: Adult Ependymoma


subject: UMLS:C4287697

object_name: melanoma


subject: UMLS:C2987342

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: Immune defect


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: rheumatoid arthritis


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Crohn's aggravated


subject: CHEBI:46081

subject_name: Fluconazole


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:71226663

object_name: Recurrent Hematologic Malignancy


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab


subject: UNII:4Z63YK6E0E


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C5383290

subject_name: hyaluronidase-fihj


subject: UMLS:C5383290


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab


subject: UNII:LDJ89SS0YG


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: UNII:QQA9MLH692

subject_name: Tafasitamab


subject: UNII:QQA9MLH692


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: CHEBI:231598

subject_name: Tazemetostat


subject: CHEBI:231598


subject: UMLS:C3658787

object_name: long COVID-19


subject: CHEBI:132922

object_name: thyroid disease


subject: CHEBI:132922

object_name: reported prior thyroid disease (history)


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Impacted third molar tooth


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: small cell lung carcinoma


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Her2-receptor negative breast cancer


subject: CHEBI:47898

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:47898

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:47898

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:47898

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:47898

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:47898

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:47898

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:47898

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:47898

object_name: Stage IIA Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: Enteral and supplement feeds adverse reaction


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: Olive oil adverse reaction


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: Caries of infancy associated with breastfeeding


subject: CHEBI:3077

subject_name: Betamethasone

object_name: preterm premature rupture of the membranes


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Coronary Occlusion


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:29007

subject_name: Ceftriaxone

object_name: Cartilage injury


subject: CHEBI:29007

object_name: Finding of tear meniscus (eye)


subject: CHEBI:29007

object_name: Torn meniscus


subject: CHEBI:29007

object_name: Meniscus injury


subject: GTOPDB:10236

subject_name: volociximab

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:10236

object_name: clear cell renal carcinoma


subject: GTOPDB:10236

object_name: renal cell adenocarcinoma


subject: GTOPDB:10236

object_name: renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2108061

subject_name: VOLOCIXIMAB


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: CHEMBL.COMPOUND:CHEMBL2108061


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: UMLS:C1541160


subject: CHEBI:10127

subject_name: Zonisamide

object_name: cocaine dependence


subject: CHEBI:10112

subject_name: Zileuton

object_name: asthma


subject: UMLS:C5854567

subject_name: NKp46/CD16-based BCMA-targeted NK Cell Engager SAR445514

object_name: Relapsed/refractory multiple myeloma


subject: UMLS:C5854567

object_name: AL amyloidosis


subject: CHEBI:80270

object_name: heart failure


subject: CHEBI:80270

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:16131070


subject: PUBCHEM.COMPOUND:16131070


subject: CHEMBL.COMPOUND:CHEMBL4594475

subject_name: GLUCAGON-LIKE PEPTIDE 1


subject: CHEMBL.COMPOUND:CHEMBL4594475


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan

object_name: melanoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: UMLS:C5891112

subject_name: PLZ4-coated Paclitaxel-loaded Micelle Formulation

object_name: superficial urinary bladder carcinoma


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: Childhood Solid Neoplasm


subject: CHEBI:95089

object_name: Adult Solid Neoplasm


subject: CHEBI:95089

object_name: glioblastoma


subject: CHEBI:95089

object_name: Brain Stem Glioblastoma


subject: CHEBI:95089

object_name: glioma susceptibility 1


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:34385

object_name: Fatigue


subject: CHEBI:34385

object_name: internuclear ophthalmoplegia


subject: PUBCHEM.COMPOUND:11842633

subject_name: velusetrag

object_name: gastroparesis


subject: PUBCHEM.COMPOUND:11842633

object_name: Gastroparesis, CTCAE


subject: UNII:J4VNV64ARB

subject_name: Velusetrag


subject: UNII:J4VNV64ARB


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: Iron deficiency


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Gender Dysphoria


subject: CHEBI:3215

object_name: gender incongruence


subject: CHEBI:4717

subject_name: Droperidol

object_name: cyclic vomiting syndrome


subject: CHEBI:5613

subject_name: Haloperidol


subject: CHEBI:7773

subject_name: Ondansetron


subject: UNII:KT0ZQ64X1A

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:KT0ZQ64X1A

object_name: Recurrent ovarian cancer


subject: UNII:KT0ZQ64X1A

object_name: recurrent primary peritoneal cavity cancer


subject: CHEBI:31607

subject_name: Ferrous fumarate

object_name: infectious disease


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: UNII:2HOK1JQ203

object_name: cancer


subject: UNII:2HOK1JQ203

object_name: neoplasm


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)

object_name: precursor B-cell acute lymphoblastic leukemia


subject: UniProtKB:P47802

object_name: B-cell acute lymphoblastic leukemia


subject: PR:000010755


subject: PR:000010755


subject: UMLS:C0733521

subject_name: Ara-C


subject: MESH:D010919

subject_name: Placebos

object_name: Disinhibition


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Bone fracture


subject: CHEBI:94518

object_name: Fracture, CTCAE


subject: CHEBI:6801

subject_name: Metformin

object_name: Horizontal alveolar bone loss


subject: CHEBI:145924

subject_name: Kaletra

object_name: Pediatric AIDS


subject: CHEBI:31781

subject_name: Lopinavir


subject: RXCUI:284756


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:63613

subject_name: Nevirapine


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:31239

subject_name: Arotinolol hydrochloride

object_name: chronic kidney disease


subject: CHEBI:31239

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:135569

subject_name: Arotinolol


subject: CHEBI:135569


subject: UMLS:C0873154

subject_name: arotinolol hydrochloride


subject: UMLS:C0873154


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: hereditary hemorrhagic telangiectasia


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: hemicrania continua


subject: UMLS:C4723181

subject_name: CUSTODIOL HTK SOLN

object_name: cardiac arrest


subject: UNII:OJY3SK9H5F

subject_name: Firategrast

object_name: multiple sclerosis


subject: CHEBI:167309

subject_name: Methadone

object_name: Opioid use, unspecified with withdrawal


subject: PUBCHEM.COMPOUND:22671105

subject_name: Edotecarin

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:22671105

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:22671105

object_name: breast cancer


subject: CHEBI:63631

subject_name: Topiramate

object_name: Tourette syndrome


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Toxicity due to radiotherapy


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: nasopharyngeal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Nasopharyngeal Keratinizing Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:73611

subject_name: Met-Gly

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: CHEBI:138655

object_name: liver cancer


subject: CHEBI:138655

object_name: liver neoplasm


subject: CHEBI:138655

object_name: Adult Liver Carcinoma


subject: PR:000015485

subject_name: spermatogenesis-associated protein 2


subject: PR:000015485


subject: PR:000015485


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Pruritus, CTCAE


subject: CHEBI:28939

object_name: Pruritus


subject: CHEBI:28939

object_name: skin disorder


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Pathologic vasoconstriction


subject: PUBCHEM.COMPOUND:5281767

object_name: Vasoconstriction


subject: PUBCHEM.COMPOUND:5281767

object_name: Blood Pressure Finding


subject: PUBCHEM.COMPOUND:5281767

object_name: Systemic arterial pressure


subject: PUBCHEM.COMPOUND:5281767

object_name: hyperemia


subject: CHEBI:10023

subject_name: Voriconazole

object_name: cryptococcosis


subject: CHEBI:131174

subject_name: Navitoclax

object_name: adult lymphoma


subject: CHEBI:131174

object_name: lymphoma


subject: CHEBI:131174

object_name: pediatric lymphoma


subject: UMLS:C1831992

subject_name: ABT 263


subject: UMLS:C1831992


subject: UMLS:C1831992


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:56842000

subject_name: HYDROTALCITE

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:56842000

object_name: Dyspepsia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3989780

subject_name: SUCRALFATE


subject: CHEMBL.COMPOUND:CHEMBL3989780


subject: GTOPDB:7055

subject_name: sucralfate


subject: GTOPDB:7055


subject: CHEBI:72313

subject_name: pasireotide aspartate

object_name: APUdoma


subject: CHEBI:72313

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:72313

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:72313

object_name: digestive system neuroendocrine neoplasm


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: PUBCHEM.COMPOUND:11332179


subject: PUBCHEM.COMPOUND:11332179


subject: CHEBI:70839

subject_name: Dasatinib

object_name: mastocytosis


subject: CHEBI:70839

object_name: acquired polycythemia vera


subject: CHEBI:70839

object_name: disseminated eosinophilic collagen disease


subject: CHEBI:70839

object_name: Eosinophilia


subject: CHEBI:70839

object_name: idiopathic hypereosinophilic syndrome


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C1328005

object_name: myelofibrosis


subject: UMLS:C1328005


subject: UMLS:C1328005

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C1328005

object_name: acute myeloid leukemia


subject: UMLS:C1328005


subject: UMLS:C1328005


subject: UMLS:C1328005


subject: UMLS:C1328005


subject: UMLS:C1328005

object_name: Myelodysplasia


subject: UMLS:C1328005

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:53259022

object_name: hepatitis C


subject: RXCUI:220413

subject_name: Tri-Vi-Sol

object_name: vitamin D deficiency


subject: CHEBI:2904

subject_name: Atenolol

object_name: Spinal haemangioma


subject: CHEBI:2904

object_name: Spinal Neoplasm


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: KEGG.COMPOUND:C00735

subject_name: Cortisol

object_name: borderline personality disorder


subject: KEGG.COMPOUND:C00735

object_name: Adolescent Development


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17087

subject_name: ketone

object_name: polycystic kidney disease


subject: CHEBI:125628

subject_name: Alisertib

object_name: Progesterone Receptor Positive


subject: CHEBI:125628

object_name: Estrogen Receptor Positive


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: large B-cell lymphoma


subject: CHEBI:2639

subject_name: Amiloride

object_name: diabetic kidney disease


subject: CHEBI:47781

subject_name: Desipramine

object_name: Plasma cell myeloma refractory


subject: CHEBI:47781

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:47781

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:22972

subject_name: butyryl group

object_name: HIV infection


subject: CHEBI:22972

object_name: AIDS


subject: CHEBI:22927

subject_name: bromine atom


subject: CHEBI:22927


subject: CHEBI:22925

subject_name: bromide salt


subject: CHEBI:22925


subject: PUBCHEM.COMPOUND:133044

subject_name: GE 68

object_name: neuroendocrine neoplasm


subject: MESH:C000615436


subject: MESH:D003102

subject_name: Colloids

object_name: Burn injury


subject: MESH:D003102

object_name: Burn, CTCAE


subject: UMLS:C3273458

object_name: bladder tumor


subject: UMLS:C3273458

object_name: urinary bladder carcinoma


subject: UMLS:C3273458

object_name: urinary bladder cancer


subject: UMLS:C3273458

object_name: childhood bladder carcinoma


subject: UMLS:C3273458

object_name: triple-negative breast carcinoma


subject: UMLS:C3273458

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3273458

object_name: non-small cell lung carcinoma


subject: UMLS:C3273458

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3273458

object_name: clear cell renal carcinoma


subject: UMLS:C3273458

object_name: renal cell adenocarcinoma


subject: UMLS:C3273458

object_name: renal cell carcinoma


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: intestinal cancer


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Idiopathic hypercalciuria


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:499361

object_name: Ovarian cancer stage IV


subject: CHEBI:499361

object_name: Stage II Ovarian Cancer AJCC v8


subject: CHEBI:499361

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:499361

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:499361

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:499361

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:499361

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:499361

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:499361

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:499361

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:499361

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:499361

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:499361

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:499361

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:499361

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:499361

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:499361

object_name: ovarian Brenner tumor


subject: CHEBI:499361

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:499361

object_name: ovarian seromucinous carcinoma


subject: CHEBI:499361

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:499361

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:499361

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Nausea and vomiting


subject: CHEBI:31355

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:41879

object_name: Ovarian cancer stage IV


subject: CHEBI:41879

object_name: Stage II Ovarian Cancer AJCC v8


subject: CHEBI:41879

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:41879

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:41879

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:41879

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:41879

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:41879

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:41879

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:41879

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:41879

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:41879

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:41879

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:41879

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: CHEBI:41879

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:41879

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: CHEBI:41879

object_name: ovarian Brenner tumor


subject: CHEBI:41879

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:41879

object_name: ovarian seromucinous carcinoma


subject: CHEBI:41879

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:41879

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:41879

object_name: ovarian mucinous cystadenocarcinoma


subject: UMLS:C2365254

subject_name: Granisetron Transdermal Patch

object_name: Nausea and vomiting


subject: UMLS:C2365254

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2365254

object_name: Ovarian cancer stage IV


subject: UMLS:C2365254

object_name: Stage II Ovarian Cancer AJCC v8


subject: UMLS:C2365254

object_name: Ovarian epithelial cancer stage II


subject: UMLS:C2365254

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2365254

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C2365254

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2365254

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2365254

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2365254

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C2365254

object_name: undifferentiated ovarian carcinoma


subject: UMLS:C2365254

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C2365254

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C2365254

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C2365254

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C2365254

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C2365254

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C2365254

object_name: ovarian Brenner tumor


subject: UMLS:C2365254

object_name: ovarian clear cell cystadenocarcinoma


subject: UMLS:C2365254

object_name: ovarian seromucinous carcinoma


subject: UMLS:C2365254

object_name: ovarian serous cystadenocarcinoma


subject: UMLS:C2365254

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C2365254

object_name: ovarian mucinous cystadenocarcinoma


subject: UMLS:C1815097

object_name: pharyngitis


subject: UMLS:C1815097

object_name: Pharyngitis, CTCAE


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: Reperfusion Injury


subject: CHEBI:78870

object_name: myocardial infarction


subject: CHEBI:78870

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:78870

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:78870

object_name: myocardial ischemia


subject: CHEBI:78870

object_name: coronary atherosclerosis


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: Terminal illness


subject: CHEBI:38940

subject_name: Sunitinib

object_name: inflammatory breast carcinoma


subject: CHEBI:38940

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:38940

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:38940

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: Breast cancer stage II


subject: CHEBI:38940

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:38940

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: male breast carcinoma


subject: CHEBI:38940

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:38940

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:38940

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:38940

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:64816

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:64816

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:4911

subject_name: Etoposide

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:4911

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: UMLS:C4045683

object_name: coronary artery disorder


subject: UMLS:C4045683

object_name: coronary atherosclerosis


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: anaphylaxis


subject: UNII:2P471X1Z11

object_name: Anaphylaxis;non medication


subject: UNII:2P471X1Z11

object_name: Anaphylaxis, CTCAE


subject: UNII:2P471X1Z11

object_name: Bronchospasm


subject: UNII:2P471X1Z11

object_name: Bronchoconstriction


subject: UNII:2P471X1Z11

object_name: Bronchospasm, CTCAE


subject: UNII:2P471X1Z11

object_name: hypotension


subject: UNII:2P471X1Z11

object_name: Hypotension, CTCAE


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: UMLS:C0910794


subject: CHEBI:52970

object_name: HMG COA reductase inhibitor adverse reaction


subject: CHEBI:52970

object_name: Hypercholesterolemia


subject: CHEBI:52970

object_name: myopathy


subject: CHEBI:60899


subject: CHEBI:60899


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:177490


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:167578


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: CHEBI:64183


subject: CHEBI:64183


subject: CHEBI:132082

subject_name: Entinostat

object_name: Recurrent Lymphoma


subject: CHEBI:132082

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:132082

object_name: Refractory Visual Pathway Glioma


subject: CHEBI:132082

object_name: Recurrent Visual Pathway Glioma


subject: CHEBI:132082

object_name: Recurrent Childhood Visual Pathway Glioma


subject: CHEBI:132082

object_name: Refractory Primary Central Nervous System Neoplasm


subject: CHEBI:132082

object_name: Recurrent Primary Central Nervous System Neoplasm


subject: CHEBI:132082

object_name: pineal body neoplasm


subject: CHEBI:132082

object_name: brainstem neoplasm


subject: CHEBI:132082

object_name: childhood brain stem neoplasm


subject: UMLS:C4732936

object_name: Childhood Breast Carcinoma


subject: UMLS:C4732936

object_name: breast carcinoma


subject: UMLS:C4732936

object_name: breast cancer


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1517908

subject_name: DepoCyte

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C3828609

subject_name: PEP-CMV Vaccine

object_name: glioblastoma


subject: UMLS:C3828609

object_name: Childhood Glioblastoma


subject: UMLS:C3828609

object_name: adult glioblastoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: lymphoblastic lymphoma


subject: CHEBI:52717

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:52717

object_name: Childhood Lymphoblastic Lymphoma


subject: UNII:D1LXQ45S1O

subject_name: Cerdulatinib

object_name: hepatosplenic T-cell lymphoma


subject: UNII:D1LXQ45S1O

object_name: anaplastic large cell lymphoma


subject: UNII:D1LXQ45S1O

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C3539110

subject_name: house dust mites (allergen extract)

object_name: IgE-mediated allergic asthma


subject: UMLS:C3539110

object_name: extrinsic asthma


subject: CHEBI:4445

subject_name: Desflurane

object_name: Pelvis fracture


subject: CHEBI:4445

object_name: Hip Fracture, CTCAE


subject: CHEBI:85993

subject_name: Palbociclib

object_name: B-cell neoplasm


subject: UMLS:C4722639

subject_name: BCR-ABL Inhibitor

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C1655276

subject_name: T-KI


subject: CHEBI:127105

subject_name: tribromsalan

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C5789799

subject_name: finasteride topical

object_name: Idiopathic hirsutism


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Malignant Solid Neoplasm


subject: CHEBI:173077


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: outcomes general quality of life


subject: PUBCHEM.COMPOUND:44151801

object_name: Perceived quality of life


subject: PUBCHEM.COMPOUND:44151801

object_name: Good quality of life


subject: PUBCHEM.COMPOUND:44151801

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:44151801

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:44151801

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:44151801

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:44151801

object_name: Disorder due to radiotherapy


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Acinetobacter infectious disease


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Infiltration


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C5667037

subject_name: Anti-CD20 Antibody-drug Conjugate MRG001

object_name: Wound of abdomen


subject: UMLS:C5667037

object_name: Cutaneous wound


subject: UNII:W9Y8L7GP4C

subject_name: Cetrotide

object_name: Other complications associated with artificial fertilization


subject: CHEBI:59224

subject_name: Cetrorelix


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: pancreatitis


subject: CHEBI:4466

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:4466

object_name: Pancreatitis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:18218213

subject_name: QW

object_name: anemia


subject: PUBCHEM.COMPOUND:18218213

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:18218213

object_name: neoplasm


subject: CHEBI:141431

subject_name: Gln-Trp


subject: CHEBI:141431


subject: CHEBI:141431


subject: PR:000015169

subject_name: sodium/glucose cotransporter 2

object_name: coronary artery disorder


subject: PR:000015169

object_name: coronary atherosclerosis


subject: PR:000030286

subject_name: probable glucose sensor protein SLC5A4


subject: PR:000030286


subject: UMLS:C1999216

subject_name: Inhibitor


subject: UMLS:C1999216


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: sarcoidosis


subject: UNII:B72HH48FLU

object_name: sarcoidosis, susceptibility to, 1


subject: DRUGBANK:DB15654

subject_name: Moderna COVID-19 Vaccine

object_name: Rheumatism


subject: DRUGBANK:DB15654

object_name: EXCESS LMW-DNA


subject: DRUGBANK:DB15654

object_name: st. Louis encephalitis


subject: DRUGBANK:DB15654

object_name: rheumatoid arthritis


subject: UMLS:C0666155

subject_name: ABT 089


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Stage IIIC Colorectal Cancer AJCC v7


subject: CHEBI:201431

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:201431

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:201431

object_name: Stage IIIB Colorectal Cancer AJCC v7


subject: CHEBI:201431

object_name: Stage IIIA Colorectal Cancer AJCC v7


subject: CHEBI:201431

object_name: Colorectal cancer recurrent


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:90227

subject_name: Selumetinib


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: retinopathy of prematurity


subject: CHEBI:41879

object_name: exudative vitreoretinopathy 1


subject: CHEBI:41879

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:31781

subject_name: Lopinavir

object_name: lipodystrophy


subject: CHEBI:31781

object_name: Lipoatrophy


subject: CHEBI:31607

subject_name: Ferrous fumarate

object_name: lead poisoning


subject: CHEBI:36560

subject_name: Zinc oxide


subject: UNII:2P6O7CFW5K

subject_name: Triheptanoin

object_name: pyruvate dehydrogenase E1-alpha deficiency


subject: UNII:2P6O7CFW5K

object_name: pyruvate dehydrogenase deficiency


subject: UNII:2P6O7CFW5K

object_name: Decreased activity of the pyruvate dehydrogenase complex


subject: UMLS:C5417882

subject_name: Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318

object_name: non-small cell lung carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Metastatic malignant neoplasm to soft tissues


subject: UMLS:C2826154

subject_name: pTVG-HP Plasmid DNA Vaccine

object_name: hormone-resistant prostate carcinoma


subject: UMLS:C2826154

object_name: metastatic prostate carcinoma


subject: UMLS:C2826154

object_name: Stage IV Prostate Cancer AJCC v6


subject: UMLS:C2826154

object_name: Carcinoma of the prostate stage IV


subject: UMLS:C2826154

object_name: Stage IV Prostate Cancer AJCC v7


subject: UMLS:C2826154

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C2826154

object_name: Prostate cancer recurrent


subject: UMLS:C2826154

object_name: Metastatic malignant neoplasm to bone


subject: UMLS:C2826154

object_name: prostate adenocarcinoma


subject: UMLS:C2826154


subject: UNII:LH1XC916ME

object_name: scleritis


subject: CHEBI:3757

subject_name: Clonidine

object_name: sickle cell disease


subject: CHEBI:3757

object_name: Vaso-occlusive pain episode in sickle cell disease


subject: CHEBI:31401

subject_name: Cilostazol

object_name: punctate palmoplantar keratoderma type III


subject: CHEBI:68845

subject_name: Azilsartan medoxomil

object_name: Diabetes


subject: PUBCHEM.COMPOUND:89992620

subject_name: AVENCIGUAT

object_name: liver cirrhosis


subject: UNII:ZA7KTB4PSP


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: stage I adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage II adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent tumors of the Ewing's family


subject: PUBCHEM.COMPOUND:131769963

object_name: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: metabolic disease


subject: UMLS:C0770694

object_name: vitamin D deficiency


subject: MESH:D007252

subject_name: Influenza Vaccines

object_name: diabetes mellitus


subject: MESH:D007252


subject: MESH:D007252


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C0021735

subject_name: Viraferon

object_name: stage IB melanoma


subject: UMLS:C0021735

object_name: stage IA melanoma


subject: UMLS:C0021735

object_name: stage IIA melanoma


subject: UMLS:C0021735

object_name: Stage IIA Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0021735

object_name: stage IIB melanoma


subject: UMLS:C0021735

object_name: stage IIC melanoma


subject: UMLS:C0021735

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0021735

object_name: stage IIIC melanoma


subject: UMLS:C0021735

object_name: stage IIIA melanoma


subject: UMLS:C0021735

object_name: stage IIIB melanoma


subject: UMLS:C4086835

object_name: mycosis fungoides


subject: UMLS:C4086835

object_name: Human Papillomavirus-Related Malignant Neoplasm


subject: UMLS:C4086835

object_name: squamous cell carcinoma


subject: UMLS:C4086835

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4086835

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4086835

object_name: sarcoma


subject: UMLS:C4086835

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4086835

object_name: soft tissue sarcoma


subject: UMLS:C4086835

object_name: breast carcinoma


subject: UMLS:C4086835

object_name: melanoma


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000014196


subject: PR:000014196


subject: PR:000014196


subject: PR:000014196


subject: PR:000014196


subject: PR:000014196


subject: PR:000014196


subject: PR:000014196


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: PR:000001919


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors


subject: UMLS:C5392068

object_name: Solid Neoplasm


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: UMLS:C5392068


subject: CHEBI:64312

subject_name: Memantine

object_name: psychosis


subject: CHEBI:64312

object_name: Nonorganic psychosis


subject: CHEBI:64312

object_name: Psychosis, CTCAE


subject: CHEBI:64312

object_name: Negative symptoms co-occurrent and due to primary psychotic disorder


subject: UMLS:C2348252

subject_name: Diclofenac Sodium Gel

object_name: Radicular Cyst


subject: CHEBI:9622

subject_name: Tolterodine

object_name: Urinary incontinence


subject: CHEBI:9622

object_name: Urinary Incontinence, CTCAE 5.0


subject: PUBCHEM.COMPOUND:5284632

subject_name: Trospium


subject: PUBCHEM.COMPOUND:5284632


subject: UNII:DL772G3NN7

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:154642729

object_name: psoriasis


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: Hypopigmented scar


subject: CHEBI:51230

object_name: Burn scar


subject: CHEBI:51230

object_name: Cicatrization


subject: CHEBI:51230

object_name: hypopigmentation of the skin


subject: CHEBI:51230

object_name: Cicatrix, Hypertrophic


subject: CHEBI:51230

object_name: skin pigmentation disorder


subject: CHEBI:51230

object_name: Laser burn


subject: CHEBI:231679

subject_name: ipilimumab

object_name: HER2-positive gastric cancer


subject: CHEBI:231679

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C1657403

subject_name: Clotrimazole Troche

object_name: chronic kidney disease


subject: UMLS:C1657403

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:9916099

subject_name: Letermovir

object_name: Cytomegalovirus infection reactivation


subject: PUBCHEM.COMPOUND:9916099

object_name: Cytomegalovirus Infection Reactivation, CTCAE


subject: UNII:WO97N24A47

subject_name: Miridesap

object_name: amyloidosis


subject: PR:000006435

subject_name: acyl-CoA wax alcohol acyltransferase 2

object_name: arthritis


subject: PR:000006435

object_name: Arthritis, CTCAE


subject: PUBCHEM.COMPOUND:6436057

subject_name: PROCHLORPERAZINE MALEATE

object_name: acute mountain sickness


subject: PUBCHEM.COMPOUND:3367

object_name: cardiac conduction defect


subject: PUBCHEM.COMPOUND:3367

object_name: Schnyder corneal dystrophy


subject: PUBCHEM.COMPOUND:3367

object_name: spondylocostal dysostosis


subject: PUBCHEM.COMPOUND:3367

object_name: systemic primary carnitine deficiency disease


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C1452745

object_name: portal hypertension


subject: UMLS:C1452745

object_name: Portal Hypertension, CTCAE


subject: UMLS:C0556106

subject_name: Dietary fibre supplementation

object_name: hypertension


subject: UMLS:C0556106

object_name: Hypertension, CTCAE


subject: UMLS:C0556106

object_name: inherited lipid metabolism disorder


subject: UMLS:C0556106

object_name: Dyslipidemia


subject: UMLS:C0556106

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C0556106

object_name: obesity


subject: UMLS:C0556106

object_name: Obesity, CTCAE


subject: UMLS:C0556106

object_name: hyperglycemia


subject: UMLS:C0556106

object_name: Hyperglycemia, CTCAE


subject: UMLS:C0556106

object_name: Glucose in blood specimen above reference range


subject: UMLS:C0556106

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0556106

object_name: metabolic syndrome X


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:6I3O3W6O3B

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:6I3O3W6O3B

object_name: Indolent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:11654566


subject: PUBCHEM.COMPOUND:11654566


subject: UNII:P8B61X2X2D

object_name: type 2 diabetes mellitus


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:6067

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:6067

object_name: Adult Mixed Glioma


subject: CHEBI:6067

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:6067

object_name: Adult Gliosarcoma


subject: CHEBI:6067

object_name: adult glioblastoma


subject: CHEBI:6067

object_name: adult oligodendroglioma


subject: CHEBI:6067

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:6067

object_name: Adult Diffuse Astrocytoma


subject: PUBCHEM.COMPOUND:26945

subject_name: Aqua-cem

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:26945

object_name: gastroparesis


subject: PUBCHEM.COMPOUND:26945

object_name: Gastroparesis, CTCAE


subject: CHEBI:8871

subject_name: Risperidone

object_name: intermittent explosive disorder


subject: CHEBI:8871

object_name: adjustment disorder


subject: CHEBI:8871

object_name: Disinhibition


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: malignant soft tissue neoplasm


subject: CHEBI:135918

object_name: sarcoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:91400

subject_name: Afatinib

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5889748

subject_name: Lysosomal Acid Glucosylceramidase, Human

object_name: Gaucher disease


subject: UMLS:C0017768

subject_name: GLUCOSYLCERAMIDASE


subject: UMLS:C0112708

subject_name: Trelstar

object_name: Malignant neoplasm of female breast


subject: UMLS:C0112708

object_name: acute leukemia


subject: UMLS:C0112708

object_name: adult lymphoma


subject: UMLS:C0112708

object_name: lymphoma


subject: UMLS:C0112708

object_name: pediatric lymphoma


subject: UMLS:C0112708

object_name: Ewing sarcoma


subject: UMLS:C0112708

object_name: pediatric osteosarcoma


subject: UMLS:C0112708

object_name: Osteosarcoma


subject: UMLS:C0112708

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C0112708

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C0112708


subject: UMLS:C0112708

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C0112708

object_name: soft tissue sarcoma


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: oropharyngeal carcinoma


subject: CHEBI:46058

object_name: oropharynx cancer


subject: CHEBI:46058

object_name: oral cavity squamous cell carcinoma


subject: UMLS:C1959641

subject_name: Lavandula angustifolia (antigen)

object_name: anxiety


subject: UMLS:C1959641

object_name: anxiety disorder


subject: UMLS:C1959641

object_name: Anxiety symptoms


subject: UMLS:C1959641

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C1959641

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C1959641

object_name: Pain, Procedural


subject: UMLS:C3542425

subject_name: Lavandula angustifolia whole extract


subject: UMLS:C3542425


subject: UMLS:C3542425


subject: UMLS:C3542425


subject: UMLS:C3542425


subject: UMLS:C3542425


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: precursor B-cell acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: B-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:1805

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: acute biphenotypic leukemia


subject: CHEBI:191174

object_name: mixed phenotype acute leukemia


subject: PR:000011357

subject_name: NPC intracellular cholesterol transporter 2

object_name: Pregnant


subject: UniProtKB:P03114

subject_name: VE1_HPV16 Replication protein E1 (sprot)


subject: CHEBI:4670

subject_name: Dobutamine

object_name: acute respiratory distress syndrome


subject: CHEBI:4670

object_name: acute lung injury


subject: UMLS:C0042397

subject_name: Vasoconstrictor Agents


subject: UMLS:C0042397


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:33569


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: PUBCHEM.COMPOUND:53477739


subject: PUBCHEM.COMPOUND:11979316


subject: PUBCHEM.COMPOUND:11979316


subject: UMLS:C5966161

subject_name: Vasopressin (anatomical)


subject: UMLS:C5966161


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Refractory Transformed B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:91397

object_name: Recurrent Transformed B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:187893

subject_name: Baclofen

object_name: ataxia telangiectasia


subject: CHEBI:16302

object_name: Myelodysplasia


subject: CHEBI:16302

object_name: acute lymphoblastic leukemia


subject: CHEBI:16302


subject: CHEBI:16302

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:16302

object_name: lymphoblastic lymphoma


subject: CHEBI:16302

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:16302

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:16302

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:16302

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:16302

object_name: acute myeloid leukemia


subject: CHEBI:16302

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:16302

object_name: non-Hodgkin lymphoma


subject: CHEBI:16302

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:16302

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T

object_name: acute biphenotypic leukemia


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UNII:81G40H8B0T


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: UMLS:C3714656


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: CHEBI:12777


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: UMLS:C2825076


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:2735


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C5234190

subject_name: Esperoct

object_name: hemophilia A


subject: CHEBI:167574

subject_name: Semaglutide

object_name: cystic fibrosis


subject: CHEBI:167574

object_name: cystic fibrosis-related diabetes


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Intraoperative Hemorrhage


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Human Papillomavirus-18 Positive


subject: UNII:28X28X9OKV

object_name: Human Papillomavirus-16 Positive


subject: UNII:28X28X9OKV

object_name: Anal cancer recurrent


subject: UNII:28X28X9OKV

object_name: Penis carcinoma recurrent


subject: UNII:28X28X9OKV

object_name: Stage IV Penile Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IV Anal Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:1FQ2RY5YHH

subject_name: Patiromer

object_name: End stage renal failure on dialysis


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: relapsing polychondritis


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: diabetes mellitus


subject: UMLS:C0718247

object_name: Diabetic Neuralgia


subject: CHEBI:91397

object_name: nodular lymphocyte predominant Hodgkin lymphoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: transitional cell carcinoma


subject: PR:000005931


subject: UNII:ZA45457L1K

subject_name: Evobrutinib

object_name: Multiple sclerosis relapse


subject: CHEBI:5103

subject_name: Flumazenil

object_name: dental phobia


subject: CHEBI:597326

subject_name: pyridoxal 5'-phosphate(2-)

object_name: tardive dyskinesia


subject: CHEBI:18405

subject_name: Pyridoxal phosphate


subject: CHEBI:17310

subject_name: Pyridoxal


subject: CHEBI:233453

object_name: transplantation infection


subject: CHEBI:233453

object_name: EBV Infection


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: UMLS:C4287586

subject_name: Ceftazidime/Avibactam Sodium

object_name: Febrile Neutropenia


subject: UMLS:C4287586

object_name: Febrile Neutropenia, CTCAE


subject: UMLS:C4287586

object_name: neoplasm


subject: CHEBI:231679

subject_name: ipilimumab

object_name: classic Kaposi sarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:145500

subject_name: thiencarbazone-methyl

object_name: Recurrent urinary tract infections


subject: CHEBI:35255

subject_name: Chloroform


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Rhinosinusitis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C3813201

subject_name: Oral Rehydration Solution OS-1

object_name: acute diarrhea


subject: MESH:C034130

subject_name: ORALIT


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: colorectal cancer


subject: CHEBI:132268

object_name: colorectal carcinoma


subject: CHEBI:132268

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1675748


subject: UMLS:C1675748


subject: UMLS:C1675748


subject: CHEBI:88249

subject_name: Mirdametinib


subject: CHEBI:88249


subject: CHEBI:88249


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Burn injury


subject: UMLS:C0013227

object_name: Wounds and Injuries


subject: UMLS:C0013227

object_name: Partial thickness burn


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: CHEBI:34385

subject_name: Dalfampridine


subject: CHEBI:34385


subject: UNII:CUJ2MVI71Y

subject_name: Daclizumab

object_name: T-cell leukemia


subject: UNII:CUJ2MVI71Y

object_name: human T-lymphotropic virus 1 infectious disease


subject: UMLS:C0281549

subject_name: Zenapax


subject: UMLS:C0281549


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Colonization


subject: CHEBI:53514

subject_name: pluronic


subject: UMLS:C0032251

subject_name: Pluronics


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:55438

subject_name: Angiotensin 1-7

object_name: Ischemic stroke


subject: UMLS:C0103306


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: triple-negative breast carcinoma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Hip dysplasia


subject: DRUGBANK:DB06184

object_name: pancreatic neoplasm


subject: DRUGBANK:DB06184

object_name: benign neoplasm of pancreas


subject: DRUGBANK:DB06184

object_name: Pancreas problem


subject: DRUGBANK:DB06184

object_name: carcinoma


subject: CHEBI:84500

subject_name: varenicline

object_name: Machado-Joseph disease


subject: PUBCHEM.COMPOUND:6420057

subject_name: METOPROLOL TARTRATE

object_name: Angina pectoris


subject: CHEBI:6904

subject_name: Metoprolol


subject: UNII:RB0RV8I60K

subject_name: HUMAN C1-ESTERASE INHIBITOR, RECOMBINANT

object_name: hereditary angioedema


subject: UMLS:C5418039

subject_name: AXL/FLT3/VEGFR2 Inhibitor KC1036

object_name: esophageal squamous cell carcinoma


subject: PUBCHEM.COMPOUND:9831761

subject_name: Hydrochlorothiazide; irbesartan

object_name: hypertension


subject: PUBCHEM.COMPOUND:9831761

object_name: Hypertension, CTCAE


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C2958914

object_name: amyotrophic lateral sclerosis


subject: UMLS:C2958914

object_name: Parkinson disease


subject: CHEBI:70707

subject_name: Vilazodone

object_name: social phobia


subject: CHEBI:177705

subject_name: Birinapant

object_name: chronic myelomonocytic leukemia


subject: UMLS:C2981814


subject: UMLS:C5203186

subject_name: Atezolizumab Liquid Injection

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C1508862

subject_name: INJECTION, BEVACIZUMAB, 10 MG, Administered


subject: UMLS:C2729368

subject_name: INJECTION, BEVACIZUMAB, 0.25 MG, Administered


subject: UMLS:C5203354

subject_name: Bevacizumab Liquid Injection


subject: CHEBI:7496

subject_name: Nelfinavir


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: cutaneous leishmaniasis


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Metastatic Unresectable Sarcoma


subject: CHEBI:71219

object_name: Metastatic synovial sarcoma


subject: CHEBI:71219

object_name: Unresectable Leiomyosarcoma


subject: CHEBI:71219

object_name: Metastatic leiomyosarcoma


subject: CHEBI:71219

object_name: High Grade Sarcoma


subject: CHEBI:71219

object_name: Malignant fibrous histiocytoma metastatic


subject: CHEBI:71219

object_name: Synovial sarcoma recurrent


subject: CHEBI:71219

object_name: Metastatic Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:71219

object_name: Malignant fibrous histiocytoma recurrent


subject: CHEBI:71219

object_name: Stage III Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:71219

object_name: Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:71219

object_name: Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:71219

object_name: Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:71219

object_name: Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:71219

object_name: Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:71219

object_name: Stage IV Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:71219

object_name: Leiomyosarcoma recurrent


subject: CHEBI:71219

object_name: Recurrent Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: Metastatic Unresectable Sarcoma


subject: CHEBI:91450

object_name: Metastatic synovial sarcoma


subject: CHEBI:91450

object_name: Unresectable Leiomyosarcoma


subject: CHEBI:91450

object_name: Metastatic leiomyosarcoma


subject: CHEBI:91450

object_name: High Grade Sarcoma


subject: CHEBI:91450

object_name: Malignant fibrous histiocytoma metastatic


subject: CHEBI:91450

object_name: Synovial sarcoma recurrent


subject: CHEBI:91450

object_name: myxofibrosarcoma


subject: CHEBI:91450

object_name: Metastatic Malignant Peripheral Nerve Sheath Tumor


subject: CHEBI:91450

object_name: Malignant fibrous histiocytoma recurrent


subject: CHEBI:91450

object_name: Stage III Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:91450

object_name: Stage IIIA Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:91450

object_name: Stage IIIC Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:91450

object_name: Stage IIIB Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:91450

object_name: Stage IVA Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:91450

object_name: Stage IVB Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:91450

object_name: Stage IV Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:91450

object_name: Leiomyosarcoma recurrent


subject: CHEBI:91450

object_name: Recurrent Malignant Peripheral Nerve Sheath Tumor


subject: PUBCHEM.COMPOUND:6919043

subject_name: (S)-ibuprofen

object_name: Acute Pain


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: diabetic autonomic neuropathy


subject: UNII:6XLY6FY7EQ

object_name: neuralgia


subject: UNII:6XLY6FY7EQ

object_name: Neuralgia, CTCAE


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:233362

object_name: Unilateral Breast Carcinoma


subject: CHEBI:233362

object_name: Multifocal breast carcinoma


subject: CHEBI:176844

subject_name: Niraparib

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:176844

object_name: invasive breast carcinoma


subject: CHEBI:176844

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:176844

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:176844


subject: CHEBI:176844

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:176844


subject: CHEBI:176844

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:176844

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:176844

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:176844


subject: CHEBI:176844

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:176844

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:176844

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Neck Carcinoma


subject: CHEBI:85990

object_name: head and neck neoplasm


subject: UNII:D07V79Q44T

object_name: lung cancer


subject: UNII:D07V79Q44T

object_name: lung neoplasm


subject: UNII:D07V79Q44T

object_name: lung carcinoma


subject: UNII:D07V79Q44T


subject: UNII:D07V79Q44T


subject: UNII:D07V79Q44T

object_name: head and neck cancer


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: HER2 negative


subject: UMLS:C3827082


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:9150

subject_name: Simvastatin

object_name: pancreatic adenocarcinoma


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39112

subject_name: Bosutinib

object_name: chronic graft versus host disease


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: COPD exacerbation


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: Cognitive changes


subject: CHEBI:66901

subject_name: Ivacaftor

object_name: chronic pancreatitis


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Alzheimer disease type 1


subject: CHEBI:36005

object_name: dementia


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:37144

subject_name: epichlorohydrin


subject: CHEBI:37144

object_name: Alzheimer disease


subject: CHEBI:37144


subject: CHEBI:28364

subject_name: Icosapent


subject: CHEBI:28364


subject: CHEBI:28364


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:4026

object_name: obesity


subject: CHEBI:4026

object_name: Obesity, CTCAE


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Diamond-Blackfan anemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: CHEBI:4445

subject_name: Desflurane

object_name: oxygen saturation measurement


subject: CHEBI:9130

subject_name: Sevoflurane


subject: GTOPDB:7487

subject_name: alpha1-proteinase inhibitor

object_name: cystic fibrosis


subject: UMLS:C0795657

subject_name: Aralast


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: UMLS:C0962969

subject_name: RAD 001

object_name: small cell lung carcinoma


subject: CHEBI:75998

subject_name: Trametinib

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:34954

subject_name: (S)-ropivacaine hydrochloride hydrate

object_name: urinary bladder carcinoma


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:76004

subject_name: Dimethyl fumarate

object_name: age-related macular degeneration


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Malignant lymphoma, stem cell type


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:9168

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:9168

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:9168

object_name: adult acute monocytic leukemia


subject: CHEBI:9168

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:9168

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:9168

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:9168

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:91654792

subject_name: Oratecan

object_name: Advanced cancer


subject: UMLS:C2981803


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic endometrioid carcinoma


subject: CHEBI:72317

object_name: endometrial clear cell adenocarcinoma


subject: CHEBI:72317

object_name: endometrial serous adenocarcinoma


subject: CHEBI:72317

object_name: endometrial mixed adenocarcinoma


subject: CHEBI:72317

object_name: endometrial adenosquamous carcinoma


subject: CHEBI:49956

subject_name: Xenon

object_name: Compulsion


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: peripheral vascular disease


subject: DRUGBANK:DB10640

object_name: peripheral arterial disease


subject: CHEBI:36467

subject_name: Ciguatoxins

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:36467

object_name: acute myeloid leukemia


subject: CHEBI:36467

object_name: Higher Risk Myelodysplastic Syndrome


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C5574748

subject_name: C-Terminal Telopeptide Type 1 Collagen, human


subject: UMLS:C5574748


subject: UMLS:C5574748


subject: UMLS:C0010377

subject_name: Crotoxin


subject: UMLS:C0010377


subject: UMLS:C0010377


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)


subject: UniProtKB:P41416


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C3554917

subject_name: Abilify Maintena

object_name: bipolar disorder


subject: UMLS:C3554917

object_name: Adherence To Medication Regime


subject: UMLS:C3554917

object_name: Medication Nonadherence


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:31236


subject: CHEBI:74947

subject_name: Thalidomide

object_name: prostate neoplasm


subject: CHEBI:135928

subject_name: Doripenem

object_name: Abdominal Infection


subject: CHEBI:9168

object_name: Autoimmune anaemia


subject: CHEBI:15367

subject_name: Tretinoin


subject: PR:000015169

subject_name: sodium/glucose cotransporter 2

object_name: atrial fibrillation


subject: PR:000015169

object_name: Atrial Fibrillation by ECG Finding


subject: PR:000015169

object_name: Atrial Fibrillation, CTCAE


subject: PR:000030286

subject_name: probable glucose sensor protein SLC5A4


subject: PR:000030286


subject: PR:000030286


subject: UMLS:C1999216

subject_name: Inhibitor


subject: UMLS:C1999216


subject: UMLS:C1999216


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:25681

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:25681

object_name: Carcinoma of the prostate stage III


subject: CHEBI:25681

object_name: Stage III Prostate Cancer AJCC v6


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: UMLS:C3536908


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Aggressive Variant Prostate Carcinoma


subject: PUBCHEM.COMPOUND:126481870

subject_name: valemetostat


subject: PUBCHEM.COMPOUND:126481870

object_name: metastatic prostate carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: Metastatic urothelial carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: Clear-cell metastatic renal cell carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: PUBCHEM.COMPOUND:126481870

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:126481870

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:126481870

object_name: Stage IVA Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:126481870

object_name: Stage IVB Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:126481870

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:60RD0234VE

subject_name: Valemetostat


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: UNII:60RD0234VE


subject: PUBCHEM.COMPOUND:123807

subject_name: CCPA

object_name: osteoarthritis, knee


subject: CHEBI:177605

subject_name: Samidorphan

object_name: substance-related disorder


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: myelosuppression


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: nasal cavity neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: nasal cavity adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: paranasal sinus cancer


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911

object_name: paranasal sinus carcinoma


subject: CHEBI:4911


subject: UMLS:C1175067

object_name: prostate carcinoma


subject: CHEBI:31413

subject_name: Clobazam

object_name: Low back pain


subject: CHEBI:47499

subject_name: Imipramine


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: pulmonary sarcoidosis


subject: CHEBI:131166

subject_name: Berzosertib

object_name: Urothelial carcinoma ureter metastatic


subject: CHEBI:131166

object_name: Metastatic Bladder Urothelial Carcinoma


subject: CHEBI:131166

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:131166

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: UNII:NSC8QP4B6Z

object_name: malaria


subject: UMLS:C3884469


subject: CHEBI:42797

subject_name: Gabapentin

object_name: lung cancer


subject: CHEBI:42797

object_name: lung neoplasm


subject: CHEBI:42797

object_name: lung carcinoma


subject: UNII:V4E0A9M44Q

subject_name: Etavopivat

object_name: thalassemia


subject: CHEBI:31797

subject_name: Gadolinium DTPA

object_name: brain cancer


subject: CHEBI:31797

object_name: brain neoplasm


subject: CHEBI:180856

subject_name: Hovenoside G


subject: CHEBI:180856


subject: UMLS:C0721529

subject_name: Magnevist


subject: UMLS:C0721529


subject: UMLS:C2919045

subject_name: SH L 451 A


subject: UMLS:C2919045


subject: CHEBI:135947

subject_name: Bazedoxifene

object_name: Increased reactive oxygen species production


subject: CHEBI:135947

object_name: sleep apnea


subject: CHEBI:135947

object_name: Sleep Apnea, CTCAE


subject: DRUGBANK:DB14248

subject_name: Bos taurus gallstone

object_name: Ischemic cerebrovascular disease


subject: DRUGBANK:DB14248

object_name: Acute Ischemic Stroke


subject: DRUGBANK:DB14248

object_name: Ischemic stroke


subject: DRUGBANK:DB14248

object_name: brain small vessel disease 3


subject: PUBCHEM.COMPOUND:22833609

subject_name: Chitobiose


subject: PUBCHEM.COMPOUND:22833609


subject: PUBCHEM.COMPOUND:22833609


subject: PUBCHEM.COMPOUND:22833609


subject: PUBCHEM.COMPOUND:157010100

subject_name: Potassium citrate

object_name: acute urate nephropathy


subject: CHEBI:32139


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: invasive ductal breast carcinoma


subject: CHEBI:17347

subject_name: Testosterone

object_name: paraplegia


subject: CHEBI:3493

subject_name: Cefoperazone


subject: UMLS:C5554944

subject_name: Pan-FGFR Inhibitor ICP-192

object_name: Childhood Solid Neoplasm


subject: UMLS:C5554944

object_name: Adult Solid Neoplasm


subject: UMLS:C5554944

object_name: Solid Neoplasm


subject: UMLS:C0060061

subject_name: Fansidar

object_name: lymphoproliferative syndrome


subject: UMLS:C0060061

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: UMLS:C0060061

object_name: Autoimmunity


subject: CHEBI:9329

subject_name: Sulfadoxine


subject: CHEBI:9329


subject: CHEBI:9329


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: pouchitis


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: PUBCHEM.COMPOUND:3417


subject: CHEBI:62247


subject: CHEBI:62419


subject: CHEBI:28915

subject_name: Fosfomycin


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: CHEBI:6909

subject_name: Metronidazole


subject: UNII:07802BU06S

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C3896727

subject_name: RNR Inhibitor COH29


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Insulin Sensitivity


subject: CHEBI:85078

object_name: fatal multiple mitochondrial dysfunctions syndrome


subject: MESH:C000628491

object_name: schizoaffective disorder


subject: MESH:C000628491

object_name: schizophrenia 18


subject: MESH:C000628491

object_name: schizophrenia


subject: MESH:C000628491

object_name: Acute schizophrenia


subject: CHEBI:90227

subject_name: Selumetinib

object_name: pancreatic neoplasm


subject: CHEBI:90227

object_name: exocrine pancreatic carcinoma


subject: CHEBI:90227

object_name: malignant pancreatic neoplasm


subject: GTOPDB:8002

subject_name: bavituximab

object_name: squamous cell carcinoma


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: DRUGBANK:DB17831

subject_name: Beremagene geperpavec


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Myocardial injury


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: Parkinson disease


subject: RXCUI:798361

subject_name: Havrix

object_name: streptococcal infection


subject: CHEBI:3374

subject_name: Capsaicin

object_name: Vomiting of pregnancy


subject: CHEBI:3374

object_name: hyperemesis gravidarum


subject: CHEBI:3374

object_name: Nausea gravidarum


subject: PUBCHEM.COMPOUND:3928

subject_name: Epilincomycin

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:656509

subject_name: Lincomycin


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Lung squamous cell carcinoma metastatic


subject: CHEBI:50858

subject_name: corticosteroid

object_name: fetal growth restriction


subject: CHEBI:50858

object_name: Fetal Growth Retardation, CTCAE


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: CHEBI:33325

subject_name: radium atom

object_name: Prostatic Cancer, Castration-Resistant


subject: UMLS:C3827153


subject: UMLS:C1725180

subject_name: ranibizumab ophthalmic

object_name: Macular Edema


subject: CHEBI:15372

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:15372

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:15372

object_name: pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:129630809


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: CHEBI:59560


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:KXG2PJ551I

object_name: Metastatic Renal Cell Cancer


subject: UNII:KXG2PJ551I

object_name: Fumarate Hydratase-Deficient Renal Cell Carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: GTOPDB:8313

subject_name: talazoparib


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: neurofibromatosis 1


subject: UNII:ZL1R02VT79

object_name: neurofibromatosis type 1


subject: UNII:ZL1R02VT79

object_name: Cutaneous neurofibroma


subject: CHEBI:30006

subject_name: L-leucine residue

object_name: Diamond-Blackfan anemia


subject: CHEBI:16118

subject_name: Berberine

object_name: gastric ulcer


subject: CHEBI:16118

object_name: Gastric Ulcer, CTCAE


subject: CHEBI:261649

subject_name: Bismuth subsalicylate

object_name: chronic gastritis


subject: CHEBI:261649

object_name: Stomach cancer


subject: CHEBI:261649

object_name: gastric cancer


subject: CHEBI:261649


subject: CHEBI:261649


subject: CHEBI:261649

object_name: gastritis


subject: CHEBI:261649

object_name: Gastritis, CTCAE


subject: CHEBI:85545

subject_name: Bismuth cation


subject: CHEBI:85545


subject: CHEBI:85545


subject: CHEBI:85545


subject: CHEBI:85545


subject: CHEBI:85545


subject: CHEBI:85545


subject: CHEBI:33301

subject_name: bismuth atom


subject: CHEBI:33301


subject: CHEBI:33301


subject: CHEBI:33301


subject: CHEBI:33301


subject: CHEBI:33301


subject: CHEBI:33301


subject: UMLS:C2917658

subject_name: Bismuth [EPC]


subject: UMLS:C2917658


subject: UMLS:C2917658


subject: UMLS:C2917658


subject: UMLS:C2917658


subject: UMLS:C2917658


subject: UMLS:C2917658